A new mycinosyl rosamicin derivative produced by an engineered Micromonospora rosaria mutant with a cytochrome P450 gene disruption introducing the d-mycinose biosynthetic gene

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Industrial Microbiology & Biotechnology

• Publication date

  2014-07-22

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10295-014-1488-2PMID 25047182
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Post-PKS Tailoring Steps of the Spiramycin Macrolactone Ring in Streptomyces ambofaciens

  2013cited by this paper
• Production of a hybrid 16-membered macrolide antibiotic by genetic engineering of Micromonospora sp. TPMA0041

  2012cited by this paper
• Function of Cytochrome P450 Enzymes RosC and RosD in the Biosynthesis of Rosamicin Macrolide Antibiotic Produced by Micromonospora rosaria

  2012cited by this paper
• Isolation and characterization of 23-O-mycinosyl-20-dihydro-rosamicin: a new rosamicin analogue derived from engineered Micromonospora rosaria

  2010cited by this paper
• Genetic engineering of macrolide biosynthesis: past advances, current state, and future prospects

  2010cited by this paper
• Production of rosamicin derivatives in Micromonospora rosaria by introduction of d-mycinose biosynthetic gene with ΦC31-derived integration vector pSET152

  2009influential reference
• Novel desosaminyl derivatives of dihydrochalcomycin from a genetically engineered strain of Streptomyces sp.

  2009cited by this paper
• Functional analysis of MycCI and MycG, cytochrome P450 enzymes involved in biosynthesis of mycinamicin macrolide antibiotics.

  2008cited by this paper
• Combinatorial biosynthesis of 5-O-desosaminyl erythronolide A as a potent precursor of ketolide antibiotics.

  2008cited by this paper
• Engineering the glycosylation of natural products in actinomycetes.

  2007cited by this paper
• Biosynthesis of the macrolide antibiotic, tylosin

  2002cited by this paper
• Characterization and expression of a P-450-like mycinamicin biosynthesis gene using a novel Micromonospora-Escherichia coli shuttle cosmid vector

  1994cited by this paper
• New analogs of rosaramicin isolated from a Micromonospora strain. II. Structure determination.

  1990cited by this paper
• Mycinamicins, new macrolide antibiotics. XI. Isolation and structure elucidation of a key intermediate in the biosynthesis of the mycinamicins, mycinamicin VIII.

  1989cited by this paper
• 19-Deformyl-4'-deoxydesmycosin (TMC-016): synthesis and biological properties of a unique 16-membered macrolide antibiotic.

  1989cited by this paper
• Biosynthesis of the macrolide antibiotic tylosin. A preferred pathway from tylactone to tylosin.

  1983cited by this paper
• Syntheses of 4'-deoxy-demycarosyl tylosin and its analogues.

  1981cited by this paper
• MYCINAMICINS, NEW MACROLIDE ANTIBIOTICS. IV

  1981cited by this paper
• A new Micromonospora-produced macrolide antibiotic, rosamicin.

  1972cited by this paper

• Production of hybrid macrolide antibiotics by exploiting the specific substrate recognition characteristics of multifunctional cytochrome P450 enzyme MycG.

  2024cites this paper
• An overview of the cytochrome P450 enzymes that catalyze the same-site multistep oxidation reactions in biotechnologically relevant selected actinomycete strains

  2021cites this paper
• Oxidative Modification Enzymes in Polyketide Biosynthetic Pathways

  2019cites this paper
• Recent progress on the development of antibiotics from the genus Micromonospora

  2016cites this paper